Back
Burning Rock Biotech Ltd. 10K Form
Sell
32
BNR
Burning Rock Biotech Ltd.
Last Price:
$16.40
Seasonality Move:
-27.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNR News And Ratings
See the #1 stock for the next 7 days that we like better than BNR
BNR Financial Statistics
Sales & Book Value
| Annual Sales: | $75.1M |
|---|---|
| Cash Flow: | $3.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.17 |
| Price / Book: | 2.71 |
Profitability
| EPS (TTM): | -0.72140 |
|---|---|
| Net Income (TTM): | $-7.7M |
| Gross Margin: | $56.1M |
| Return on Equity: | -9.86% |
| Return on Assets: | -6.58% |
Burning Rock Biotech Ltd. Earnings Forecast
Key Burning Rock Biotech Ltd. Financial Ratios
-
The Gross Profit Margin over the past 9 years for BNR is 74.67%.
-
The Selling, General & Administrative Expenses for BNR have been equal to 53.98% of Gross Profit Margin.
-
The Research & Development expenses have been 30.86% of Revenue.
-
The Net Earning history of BNR is -10.26% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Burning Rock Biotech Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNR |
| CUSIP: | 12233L |
| Website: | brbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 2.99 |
| Quick Ratio: | 2.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNR Technical Analysis vs Fundamental Analysis
Sell
32
Burning Rock Biotech Ltd. (BNR)
is a Sell
Is Burning Rock Biotech Ltd. a Buy or a Sell?
-
Burning Rock Biotech Ltd. stock is rated a SellThe current Burning Rock Biotech Ltd. [BNR] share price is $16.20. The Score for BNR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.